Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Thalidomide as an inhibitor of new blood vessel growth to tumors: Phase II trials

EntreMed Inc. (ENMD), Rockville, Md.
Product: Thalidomide

Read the full 78 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE